Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028
Pharmaceuticals Global Group of Eight (G8) Industry Guide 2019-2028
The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.Key HighlightsThe G8 countries contributed $882.6 billion in 2023 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.8% between 2019 and 2023. The G8 countries are expected to reach a value of $1.03 trillion in 2028, with a CAGR of 3.3% over the 2023-28 period.Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $496.7 billion in 2023. This was followed by Japan and Germany, with a value of $94.3 and $87.2 billion, respectively.The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $579.7 billion in 2016, followed by Germany and Japan with expected values of $113.9 and $104.5 billion, respectively.ScopeSave time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals marketUse the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals marketLeading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performanceAdd weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecastsCompares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each countryReasons to BuyWhat was the size of the G8 pharmaceuticals market by value in 2023?What will be the size of the G8 pharmaceuticals market in 2028?What factors are affecting the strength of competition in the G8 pharmaceuticals market?How has the market performed over the last five years?Who are the top competitors in the G8 pharmaceuticals market?